Analyst group logo

Latest news

Comment

2024-11-20

Comment on the Danish Health Minister’s Decision to Propose a Permanent Legalization of Medical Cannabis
Read more

Equity research report

2024-11-19

Pharma Equity Group Q3-24
Read more

Comment

2024-11-15

Comment on PEG’s Q3 Report for 2024
Read more

Equity research report

2024-11-11

STENOCARE Q3-24
Read more

Comment

2024-11-06

Comment on STENOCARE’s Q3-Report 2024
Read more

Comment

2024-10-23

Comment on Pharma Equity Group’s obtained patent protection in Japan for RNX-051
Read more

Comment

2024-10-14

Comment on STENOCARE’s Updated Guidance for 2024
Read more

Comment

2024-10-07

Comment on Pharma Equity Group’s Directed Share Issue to a Premium
Read more

Equity research report

2024-09-05

ODI Pharma
Read more

Comment

2024-08-29

Comment on ODI Pharma’s Quarterly Report
Read more

Equity research report

2024-08-29

STENOCARE Q2-24
Read more

Comment

2024-08-22

Comment on STENOCARE’s Q2-report Report 2024
Read more

Video

2024-08-20

Interview with Pharma Equity Group’s CEO Thomas Kaas Selsø
Read more

Equity research report

2024-08-20

Pharma Equity Group Q2-24
Read more

Comment

2024-08-16

Comment on PEG’s Q2 Report for 2024
Read more

Comment

2024-06-26

Comment on ODI Pharma’s Strategic Market Entry to Switzerland
Read more

Equity research report

2024-06-05

ODI Pharma Q1-24
Read more

Equity research report

2024-05-08

STENOCARE Q1-24
Read more

Equity research report

2024-05-06

ODI Pharma
Read more

Video

2024-05-06

Interview with ODI Pharma’s Chairman of the Board Volker Wiederrich
Read more

Comment

2024-05-02

Comment on STENOCARE’s Q1-report Report 2024
Read more

Comment

2024-04-05

Comment on Pharma Equity Group’s Positive Final Results From the Phase II Trial of the Drug Candidate RNX-051
Read more

Equity research report

2024-03-27

Movinn Q4-23
Read more

Comment

2024-03-22

Comment on Movinn’s Annual Report
Read more

Equity research report

2024-03-22

Pharma Equity Group Q4-23
Read more

Comment

2023-12-14

Comment on STENOCARE Expanding in Australia
Read more

Comment

2023-11-23

Comment on STENOCARE Adding a new Product in Australia
Read more

Equity research report

2023-11-14

STENOCARE Q3-23
Read more

Equity research report

2023-11-10

Movinn Q3-23
Read more

Comment

2023-11-09

Comment on STENOCARE’s Q3-report
Read more

Comment

2023-11-07

Comment on STENOCARE’s Updated Guidance and One-off Return of Products from Norway
Read more

Comment

2023-11-03

Analyst Group Comments on Movinn’s Q3-report
Read more

Equity research report

2023-10-23

OrderYOYO Q3-23
Read more

Comment

2023-10-18

Analyst Group Comments on OrderYOYO’s Q3-23 Trading Update
Read more

Equity research report

2023-09-28

RTX
Read more

Comment

2023-09-22

Analyst Group Comments on Movinn Expands to Ludvika
Read more

Comment

2023-09-19

Comment on STENOCARE’s Market Update
Read more

Equity research report

2023-09-11

Brain+ H2-23
Read more

Comment

2023-09-01

Analyst Group Comments on Brain+’s Semi-Annual Report 2023
Read more

Equity research report

2023-09-01

Movinn Q2-23
Read more

Equity research report

2023-08-30

OrderYOYO
Read more

Comment

2023-08-25

Comment on Movinn’s Q2-report
Read more

Equity research report

2023-08-24

STENOCARE Q2-23
Read more

Comment

2023-08-22

Analyst Group Comments on OrderYOYO’s H1-23 Report
Read more

Comment

2023-07-18

Analyst Group Comments on OrderYOYO’s Q2-23 Trading Update
Read more

Equity research report

2023-06-28

STENOCARE
Read more

Comment

2023-06-20

Comment on STENOCARE’s Q1-Report 2023
Read more

Comment

2023-05-30

Comment on STENOCARE Launching an IT-platform for Online Clinics
Read more

Comment

2023-05-16

Comment on STENOCARE’s Rights Issue
Read more

Equity research report

2023-05-11

Brain+ Q1-23
Read more

Equity research report

2023-05-11

Movinn Q1-23
Read more

Comment

2023-05-04

Analyst Groups Comment on Movinn’s Q1-report
Read more

Comment

2023-05-02

Analyst Group Comments on Brain+’s Annual Report 2022
Read more

Comment

2023-04-17

Analyst Group Comments on OrderYOYO’s Q1 Performance and Acquisition of Kingfood
Read more

Equity research report

2023-04-12

Movinn
Read more

Equity research report

2023-03-29

OrderYOYO
Read more

Comment

2023-03-21

Analyst Group Comments on OrderYOYO’s Annual Report 2022
Read more

Equity research report

2023-03-02

STENOCARE Q4-22
Read more

Equity research report

2022-12-12

STENOCARE
Read more

Equity research report

2022-10-27

OrderYOYO
Read more

Comment

2022-08-30

Analyst Group’s comment on Trophy Games acquisition and management appointment
Read more

Equity research report

2022-08-22

Trophy Games
Read more

Comment

2022-08-17

Analyst Group’s comment on Trophy Games H1 report
Read more

Comment

2022-06-20

Comment on OrderYOYO’s merger with German app smart
Read more

Comment

2022-05-16

Analyst Groups comment on Trophy Games announcement
Read more

Equity research report

2022-04-07

WirTek
Read more

Equity research report

2022-04-07

CirChem
Read more

Equity research report

2022-03-30

OrderYOYO Q4-21
Read more

Equity research report

2022-03-30

Anima Group
Read more

Equity research report

2022-03-23

Transfer Group
Read more

Comment

2022-03-22

Comment on OrderYOYO’s Annual Report 2021
Read more

Equity research report

2022-03-17

SameSystem
Read more

Equity research report

2022-03-17

Carbiotix Q4-21
Read more

Equity research report

2022-03-16

Scandinavian Medical Solutions
Read more

Equity research report

2022-03-13

Fantasma Games
Read more

Equity research report

2022-03-10

First Venture Q4-21
Read more

Equity research report

2022-03-10

Cline Scientific Q4-21
Read more

Equity research report

2022-03-09

Trophy Games
Read more

Equity research report

2022-03-09

Realheart Q4-21
Read more

Equity research report

2022-03-08

NOSIUM Q4-21
Read more

Newsletter

Subscribe to be the first to get our news and latest reports